PHARMAEXCEED is available to join international partnerships applying for research fundings. We can provide all the background related to GMP production of Lyosecretome and we are interested in improving, using and testing our products in several application contexts. Please contact us.

PHARMAEXCEED is partner of University of Pavia.

PHARMAEXCEED is partner of TwinHelix, the distributor of Lyosecretome (https://www.twinhelix.eu/)

Starting December 2018, PHARMAEXCEED is partner of Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (https://www.izsler.it) for the veterinary development of Lyosecretome, GMP production, and clinical trials in equine and canine tissue regeneration.

Starting November 2018, PHARMAEXCEED is partner of the ATEx (Advanced Therapies Experiences https://www.progetti.interreg-italiasvizzera.eu/it/b/78/advancedtherapiesexperiences) consortium, funded for developing an interregional project in the framework of the Cooperation Program INTERREG V-A Italia-Svizzera 2014-2020 (http://www.interreg-italiasvizzera.eu/), ID 637541. ATEx is coordinated by the Drug Science Department of Università del Piemonte Orientale (www.dsf.uniupo.it), and is developed in partnership with the Drug Science Department of University of Pavia (http://dipsf.unipv.eu/site/home.html), APTsol Srls (http://www.aptsol.it/), Daymed Srl, and IBI SA (https://www.ibi-sa.com/).